News
Important Only
Other
BRIEF-Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital
Feb 19 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ANNOUNCES COMPLETION OF A NOVEL HEAD COIL BY TESLA FOR MEASURING BRAIN STRUCTURE LITHIUM LEVELS IN FIVE UPCOMING PHASE II CLINICAL TRIALS AT MASSACHUSETTS GENERAL HOSPITALSource text: ID:nBw3YrfS7aFurther company coverage: ALZN.OReuters
Wed, Feb 19
Other
BRIEF-Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Feb 19 (Reuters) - Twist Bioscience Corp TWST.O:TWIST BIOSCIENCE CORPORATION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw2m9mWZaFurther company coverage: TWST.OReuters
Wed, Feb 19
Other
BRIEF-Ontrak Health And Sentara Health Plans Execute Three-Year Contract Extension Following Several Expansions
Feb 19 (Reuters) - Ontrak Inc OTRK.O:ONTRAK HEALTH AND SENTARA HEALTH PLANS EXECUTE THREE-YEAR CONTRACT EXTENSION FOLLOWING SEVERAL EXPANSIONSONTRAK INC - EXTENDS PARTNERSHIP WITH SENTARA HEALTH PLANS THROUGH DECEMBER 2027Source text: ID:nBw6chb4taFurther company coverage: OTRK.OReuters
Wed, Feb 19
Other
BRIEF-Branchout Food Welcomes Jesse Thomas As Chief Brand Officer To Drive Direct-To-Consumer And Brand Strategy
Feb 19 (Reuters) - BranchOut Food Inc BOF.O:BRANCHOUT FOOD WELCOMES JESSE THOMAS AS CHIEF BRAND OFFICER TO DRIVE DIRECT-TO-CONSUMER AND BRAND STRATEGYSource text: ID:nGNX38x74sFurther company coverage: BOF.OReuters
Wed, Feb 19
Other
BRIEF-NKGen Appoints Dr. Anita Fletcher As National Principal Investigator For Phase 2A Troculeucel Trial Evaluating Moderate Alzheimer’S Disease With Adventhealth Orlando As First East Coast Site
Feb 19 (Reuters) - Nkgen Biotech Inc NKGN.O:NKGEN APPOINTS DR. ANITA FLETCHER AS NATIONAL PRINCIPAL INVESTIGATOR FOR PHASE 2A TROCULEUCEL TRIAL EVALUATING MODERATE ALZHEIMER’S DISEASE WITH ADVENTHEALTH ORLANDO AS FIRST EAST COAST SITESource text: ID:nGNX9pTy5bFurther company coverage: NKGN.OReuters
Wed, Feb 19
Other
BRIEF-AskBio Receives FDA Regenerative Medicine Advanced Therapy Designation For Parkinson’S Disease Investigational Gene Therapy
Feb 19 (Reuters) - ASKBIO RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION FOR PARKINSON’S DISEASE INVESTIGATIONAL GENE THERAPYSource text: ID:nGNX88bDLzReuters
Wed, Feb 19
Other
BRIEF-Rosebank Industries In Talks To Buy Electrical Components International
Feb 19 (Reuters) - Rosebank Industries PLC ROSE.L:POSSIBLE ACQUISITIONIN DISCUSSIONS TO ACQUIRE ELECTRICAL COMPONENTS INTERNATIONALACQUISITION TO BE FUNDED THROUGH EQUITY ISSUE AND NEW DEBT FACILITIESSource text: ID:nRSS7254XaFurther company coverage: ROSE.LReuters
Wed, Feb 19
Other
BRIEF-Top Kingwin Ltd Announces $1,000,000 Convertible Promissory Note Offering And Up To $28,500,000 Additional Note Offering
Feb 19 (Reuters) - Top KingWin Ltd WAI.O:TOP KINGWIN LTD ANNOUNCES $1,000,000 CONVERTIBLE PROMISSORY NOTE OFFERING AND UP TO $28,500,000 ADDITIONAL NOTE OFFERINGSource text: ID:nGNX9QVLKTFurther company coverage: WAI.OReuters
Wed, Feb 19
Other
BRIEF-Milestone Pharmaceuticals Inc Receives Notice Of Allowance On New U.S. Patent For Etripamil
Feb 19 (Reuters) - Milestone Pharmaceuticals Inc MIST.O:MILESTONE PHARMACEUTICALS INC: RECEIVES NOTICE OF ALLOWANCE ON NEW U.S. PATENT FOR ETRIPAMILSource text: ID:nGNX7GqZZgFurther company coverage: MIST.OReuters
Wed, Feb 19
Other
GM CFO says if US tariffs are permanent, company must consider plant locations
Feb 19 (Reuters) - General Motors CFO Paul Jacobson said Wednesday at a Barclays conference that if U.S. tariffs became permanent, the company would have to consider moving plants, but also said it has not made those decisions yet.Reuters
Wed, Feb 19
Stocks
BUZZ-Krystal Biotech rises after quarterly revenue beat
** Drug developer Krystal Biotech's KRYS.O shares rise 9.75% to $171.96** Co posts Q4 rev of $91.1 mln, beating analyst est of $90.5 mln, as per data compiled by LSEG ** Co's net income for the quarter was $45.5 million or $1.58 per share, compared with net income of $8.7 million or 31 cents...Reuters
Wed, Feb 19
Other
BRIEF-Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Feb 19 (Reuters) - Predictive Oncology Inc POAI.O:PREDICTIVE ONCOLOGY ANNOUNCES REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULESSource text: ID:nGNXmVtDjFurther company coverage: POAI.OReuters
Wed, Feb 19
Other
Finance bosses press UK's Reeves to ease investment taxes, sources say
Adds finance ministry declined to comment in paragraph 9By Iain Withers LONDON, Feb 19 (Reuters) - Bosses from global financial firms pressed Britain's finance minister Rachel Reeves on Wednesday to improve tax incentives for UK consumers to invest and to boost UK competitiveness, four source...Reuters
Wed, Feb 19
Stocks
Shift4 Payments delivers Q4 beat, shares tank on $2.5 bln Global Blue acquisition
Investing.com -- Shift4 Payments reported stronger-than-expected fourth-quarter earnings, but its shares tanked roughly 8% at Wednesday market open as it announced a $2.5 billion acquisition of GlobalInvesting.com
Wed, Feb 19
Other
BRIEF-Recce Pharmaceuticals Reports Positive Data From Phase Ii Trial Of Recce® 327 Gel In Acute Bacterial Skin And Skin Structure Infections, Supporting Accelerated Commercialization Pathway
Feb 19 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX:RECCE PHARMACEUTICALS REPORTS POSITIVE DATA FROM PHASE II TRIAL OF RECCE® 327 GEL IN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS, SUPPORTING ACCELERATED COMMERCIALIZATION PATHWAYRECCE PHARMACEUTICALS LTD - R327G ACHIEVES 93% PRIMARY EFFICACY...Reuters
Wed, Feb 19
